Kmc Speciality Hospitals India Ltd vs Modern Diagnostic Research Centre Ltd Stock Comparison
Kmc Speciality Hospitals India Ltd vs Modern Diagnostic Research Centre Ltd Stock Comparison
Last Updated on: Nov 01, 2026
Key Highlights
The Latest Trading Price of KMC Speciality Hospitals (India) Ltd is ₹ 148.5 as of 30 Oct 15:30
. The P/E Ratio of KMC Speciality Hospitals (India) Ltd changed from 28 on March 2021 to 27.4 on March 2026 . This represents a CAGR of -0.36% over 6 yearsThe P/E Ratio of Modern Diagnostic & Research Centre Ltd changed from 15.4 on March 2026 to 15.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of KMC Speciality Hospitals (India) Ltd changed from ₹ 355.56 crore on March 2021 to ₹ 1284 crore on March 2026 . This represents a CAGR of 23.87% over 6 yearsThe Market Cap of Modern Diagnostic & Research Centre Ltd changed from ₹ 80.96 crore on March 2026 to ₹ 80.96 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of KMC Speciality Hospitals (India) Ltd for the Jun '26 is ₹ 93.58 crore as compare to the Mar '26 revenue of ₹ 84.16 crore. This represent the growth of 11.19% The revenue of Modern Diagnostic & Research Centre Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of KMC Speciality Hospitals (India) Ltd for the Jun '26 is ₹ 30.29 crore as compare to the Mar '26 ebitda of ₹ 27.78 crore. This represent the growth of 9.04% The ebitda of Modern Diagnostic & Research Centre Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of KMC Speciality Hospitals (India) Ltd changed from ₹ 5.51 crore to ₹ 16.57 crore over 9 quarters. This represents a CAGR of 63.12%
The net profit of Modern Diagnostic & Research Centre Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0%
The Dividend Payout of KMC Speciality Hospitals (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Modern Diagnostic & Research Centre Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About KMC Speciality Hospitals (India) Ltd
KMC Speciality Hospitals (India) Limited was originally incorporated as 'Advanced Medical Care Private Limited' on December 31, 1982 and was converted into a Public Limited Company on July 15, 1988.
The name of the Company was changed to 'Seahorse Hospitals Limited' on March 21, 1995 and to its current name 'KMC Speciality Hospitals (India) Limited' with effect from October 24, 2008.
The Company is a part of the KMC Group of Hospitals based at Tiruchirappalli.
The Company is a super speciality hospital based in Trichy, belonging to the Kauvery Hospitals Group.
The Company is primarily engaged in the business of rendering medical and healthcare services.
It provide quality healthcare to patients in key specialty areas such as Neurosurgery, Cardiovascular & thoracic surgery, Orthopedics, Plastic and Reconstructive Surgery, Gynecology, Neonatology and Nephrology (including renal transplants).
About Modern Diagnostic & Research Centre Ltd
The Promoter, Mr. Devendra Singh Yadav started its operations of Diagnostic Centre in the name and style of 'Modern X-Ray and Clinical Lab' as Proprietorship firm in year 1985, which was later designated as 'Modern Diagnostic & Research Centre' in 1992.
Modern Diagnostic & Research Centre Limited was erstwhile incorporated as 'Modern Diagnostic & Research Centre Private Limited' as a private company, vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi .
Thereafter, the Company acquired the business of M/s.
Modern Diagnostics & Research Centre, a Proprietorship Concern through Business Transfer Agreement in 2013.
Subsequently, its status got converted from private limited into public limited and the name of the Company was changed to 'Modern Diagnostic & Research Centre Limited' pursuant to fresh certificate of incorporation dated December 18, 2024 issued by Registrar of Companies, Central Processing Centre.
FAQs for the comparison of KMC Speciality Hospitals (India) Ltd and Modern Diagnostic & Research Centre Ltd
Which company has a larger market capitalization, KMC Speciality Hospitals (India) Ltd or Modern Diagnostic & Research Centre Ltd?
Market cap of KMC Speciality Hospitals (India) Ltd is 2,422 Cr while Market cap of Modern Diagnostic & Research Centre Ltd is 87 Cr
What are the key factors driving the stock performance of KMC Speciality Hospitals (India) Ltd and Modern Diagnostic & Research Centre Ltd?
The stock performance of KMC Speciality Hospitals (India) Ltd and Modern Diagnostic & Research Centre Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for KMC Speciality Hospitals (India) Ltd and Modern Diagnostic & Research Centre Ltd?
As of November 1, 2026, the KMC Speciality Hospitals (India) Ltd stock price is INR ₹148.5. On the other hand, Modern Diagnostic & Research Centre Ltd stock price is INR ₹58.0.
How do dividend payouts of KMC Speciality Hospitals (India) Ltd and Modern Diagnostic & Research Centre Ltd compare?
To compare the dividend payouts of KMC Speciality Hospitals (India) Ltd and Modern Diagnostic & Research Centre Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.